{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Sellersville",
      "state": "PA",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "64305",
      "recalling_firm": "Teva Pharmaceuticals USA, Inc.",
      "address_1": "650 Cathill Rd",
      "address_2": "N/A",
      "postal_code": "18960-1512",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "NC",
      "recall_number": "D-237-2013",
      "product_description": "CLONAZEPAM ORALLY DISINTERGRATING Tablets, USP,  0.5 mg, 60 tablets (10 blister cards of 6 tablets each),  TEVA PHARMACEUTICALS USA, Sellersville PA 18960,  NDC #0555-0096-96",
      "product_quantity": "3 boxes",
      "reason_for_recall": "Failed Content Uniformity Specifications: Recall is being carried out due to an out-of-specification result for content uniformity.",
      "recall_initiation_date": "20130207",
      "center_classification_date": "20130401",
      "termination_date": "20140115",
      "report_date": "20130410",
      "code_info": "Lot # 32900136A, Exp. 05/14"
    }
  ]
}